{
Samsung Bioepis

Companies

}
001122334455554433221100
001122334455554433221100

Merck"s under-the-skin Keytruda shows promise in Phase 3 trial

Merck"s experimental under-the-skin injection of Keytruda demonstrated comparable characteristics to the intravenous version in a Phase 3 trial, prompting plans for discussions with regulators. With the IV formulation"s U.S. patent set to expire in 2028, Merck aims to sustain revenue from its leading cancer drug, which generated nearly $22 billion in sales in 2024. The subcutaneous version could offer greater convenience and is protected by new patents, but timely approval is crucial to fend off emerging biosimilar competition.
BioPharma Dive
United States Dollar Merck & Co., Inc. Celltrion Bristol-Myers Squibb Company Hoffmann-La Roche AG Amgen Inc. Samsung Bioepis Sandoz Group AG USA Show more
Healthcare, Market Report
01:00 19.11.2024
Trending
Subcategory
Corporate News Stock Market Updates Industry Trends Finance Mergers & Acquisitions Global Financial Events Retail and Consumer Goods CEO Changes Market Analysis and Predictions Banking Regulations Industry Mergers & Acquisitions Energy Sector Developments Global Trade Developments Startups & Entrepreneurship Government Policies Financial Scams and Security Domestic Politics Hedge Funds & Private Equity Supply Chain Management Central Bank Actions Workplace Trends
Countries:
USA CHN IND CHE DEU GBR FRA CAN AUS AUT SGP JPN TWN ITA NLD ESP HKG ARE VNM RUS
Companies:
Tesla, Inc. Barclays PLC JPMorgan Chase & Co. Apple Inc. UBS Group AG Capital One Financial Corporation NVIDIA Corporation The Goldman Sachs Group, Inc. Morgan Stanley Bank of America Corporation Commerzbank AG Amazon.com, Inc. Deutsche Bank RV Global PP SpaceXCoin USD Credit Suisse Real Estate Fund Siat Wells Fargo & Company Berkshire Hathaway Inc. SAP SE BNP Paribas SA Google Inc.
Currencies:
United States Dollar Euro Chinese Yuan Indian Rupee Swiss Franc British Pound Sterling Vietnamese Đồng Hong Kong Dollar Australian Dollar Singapore Dollar United Arab Emirates Dirham South Korean Won Thai Baht Norwegian Krone Danish Krone Swedish Krona Russian Ruble Ghanaian Cedi Canadian Dollar Turkish Lira
People:
Elon Musk Donald Trump Scott Bessent Jerome Powell Warren Buffett Carsten Fritsch Peter Navarro Andreas Schneemann Eva Fugger Vaibhav Taneja Dan Ives Howard Lutnick Joe Biden Bernie Ahkong Karoline Leavitt Mark Delaney Richard Fairbank Peter Grom Kubra Khan Michael Briest

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.